Subjects whose blood glucose levels are relatively high
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Subjects whose fasting blood glucose levels are not less than 100 mg/dL or HbA1c are not less than 5.6% 2)Subjects whose fasting blood glucose levels are not more than 125 mg/dL or HbA1c are not more than 6.5% 3)Subjects who have understood the purpose and contents of the study and agree to participate by signing the written informed consent
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Annual health check-up data (HbA1c, Blood glucose level) | — |
Secondary
| Measure | Time frame |
|---|---|
| Annual health check-up data (Others), Lifestyle habits questionnaire | — |
Countries
Japan
Contacts
KOBAYASHI Pharmaceutical Co., Ltd. Research & Development Dept., Healthcare Division